TNFRSF10B and colorectal carcinoma: In fact, PDT significantly increased death receptor DR4 and DR5 for TRAIL, Fas for Fas L and TNFRSF1A for TNFα (Figure 4C and Table S3), providing the molecular basis for synergy between PDT and TRAIL, Fas L, and TNFα in the killing of CRC cells.